|
 |
|
|||||||
|
|||||||||
© 2001 by the American Diabetes Association, Inc.
Type 2 Diabetes Impairs Splanchnic Uptake of Glucose but Does Not Alter Intestinal Glucose Absorption During Enteral Glucose Feeding
Additional Evidence for a Defect in Hepatic Glucokinase Activity
Division of Endocrinology, Metabolism and Nutrition, Mayo Clinic and Foundation, Rochester, Minnesota
We have previously reported that splanchnic glucose uptake, hepatic glycogen synthesis, and hepatic glucokinase activity are decreased in people with type 2 diabetes during intravenous glucose infusion. To determine whether these defects are also present during more physiological enteral glucose administration, we studied 11 diabetic and 14 nondiabetic volunteers using a combined organ catheterization-tracer infusion technique. Glucose was infused into the duodenum at a rate of 22 µmol · kg-1 · min-1 while supplemental glucose was given intravenously to clamp glucose at 
10 mmol/l in both groups. Endogenous hormone secretion was inhibited with somatostatin, and insulin was infused to maintain plasma concentrations at 300 pmol/l (i.e., twofold higher than our previous experiments). Total body glucose disappearance, splanchnic, and leg glucose extractions were markedly lower (P < 0.01) in the diabetic subjects than in the nondiabetic subjects. UDP-glucose flux, a measure of glycogen synthesis, was 35% lower (P < 0.02) in the diabetic subjects than in the nondiabetic subjects. This was entirely accounted for by a decrease (P < 0.01) in the contribution of extracellular glucose because the contribution of the indirect pathway to hepatic glycogen synthesis was similar between groups. Neither endogenous and splanchnic glucose productions nor rates of appearance of the intraduodenally infused glucose in the portal vein differed between groups. In summary, both muscle and splanchnic glucose uptake are impaired in type 2 diabetes during enteral glucose administration. The defect in splanchnic glucose uptake appears to be due to decreased uptake of extracellular glucose, implying decreased glucokinase activity. Thus, abnormal hepatic and muscle (but not gut) glucose metabolism are likely to contribute to postprandial hyperglycemia in people with type 2 diabetes.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  J.-S. Shin, T. P. Torres, R. L. Catlin, E. P. Donahue, and M. Shiota A defect in glucose-induced dissociation of glucokinase from the regulatory protein in Zucker diabetic fatty rats in the early stage of diabetes Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1381 - R1390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Fujimoto, T. P. Torres, E. P. Donahue, and M. Shiota Glucose Toxicity Is Responsible for the Development of Impaired Regulation of Endogenous Glucose Production and Hepatic Glucokinase in Zucker Diabetic Fatty Rats Diabetes, September 1, 2006; 55(9): 2479 - 2490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Kishore, J. Tonelli, S. Koppaka, C. Fratila, A. Bose, D.-E. Lee, K. Reddy, and M. Hawkins Time-Dependent Effects of Free Fatty Acids on Glucose Effectiveness in Type 2 Diabetes Diabetes, June 1, 2006; 55(6): 1761 - 1768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Basu, R. Singh, A. Basu, C.M. Johnson, and R. A. Rizza Effect of Nutrient Ingestion on Total-Body and Splanchnic Cortisol Production in Humans Diabetes, March 1, 2006; 55(3): 667 - 674. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Moore, K. Kimura, H. Shibata, T. Honjoh, M. Saito, C. A. Everett, M. S. Smith, and A. D. Cherrington Portal 5-hydroxytryptophan infusion enhances glucose disposal in conscious dogs Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E225 - E231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Basu, R. J. Singh, A. Basu, E. G. Chittilapilly, M. C. Johnson, G. Toffolo, C. Cobelli, and R. A. Rizza Obesity and Type 2 Diabetes Do Not Alter Splanchnic Cortisol Production in Humans J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3919 - 3926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Basu, V. Chandramouli, B. Dicke, B. Landau, and R. Rizza Obesity and Type 2 Diabetes Impair Insulin-Induced Suppression of Glycogenolysis as Well as Gluconeogenesis Diabetes, July 1, 2005; 54(7): 1942 - 1948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Krssak, A. Brehm, E. Bernroider, C. Anderwald, P. Nowotny, C. D. Man, C. Cobelli, G. W. Cline, G. I. Shulman, W. Waldhausl, et al. Alterations in Postprandial Hepatic Glycogen Metabolism in Type 2 Diabetes Diabetes, December 1, 2004; 53(12): 3048 - 3056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yuasa, R. Kakuhata, K. Kishi, T. Obata, Y. Shinohara, Y. Bando, K. Izumi, F. Kajiura, M. Matsumoto, and Y. Ebina Platelet-Derived Growth Factor Stimulates Glucose Transport in Skeletal Muscles of Transgenic Mice Specifically Expressing Platelet-Derived Growth Factor Receptor in the Muscle, but It Does Not Affect Blood Glucose Levels Diabetes, November 1, 2004; 53(11): 2776 - 2786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Fujimoto, E. P. Donahue, and M. Shiota Defect in glucokinase translocation in Zucker diabetic fatty rats Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E414 - E423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Basu, A. Basu, C. M. Johnson, W. F. Schwenk, and R. A. Rizza Insulin Dose-Response Curves for Stimulation of Splanchnic Glucose Uptake and Suppression of Endogenous Glucose Production Differ in Nondiabetic Humans and Are Abnormal in People With Type 2 Diabetes Diabetes, August 1, 2004; 53(8): 2042 - 2050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Basu, R. J. Singh, A. Basu, E. G. Chittilapilly, C. M. Johnson, G. Toffolo, C. Cobelli, and R. A. Rizza Splanchnic Cortisol Production Occurs in Humans: Evidence for Conversion of Cortisone to Cortisol Via the 11-{beta} Hydroxysteroid Dehydrogenase (11{beta}-HSD) Type 1 Pathway Diabetes, August 1, 2004; 53(8): 2051 - 2059. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Basu, W. F. Schwenk, and R. A. Rizza Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E55 - E62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Fery, L. Tappy, J. Deviere, and E. O. Balasse Comparison of intraduodenal and intravenous glucose metabolism under clamp conditions in humans Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E176 - E183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Minokoshi, C. R. Kahn, and B. B. Kahn Tissue-specific Ablation of the GLUT4 Glucose Transporter or the Insulin Receptor Challenges Assumptions about Insulin Action and Glucose Homeostasis J. Biol. Chem., September 5, 2003; 278(36): 33609 - 33612. [Full Text] [PDF]
|
|
|
|
|
|
F. Zangeneh, R. Basu, P. Shah, P. Arora, M. Camilleri, and R. A. Rizza Enteral infusion of glucose at rates approximating EGP enhances glucose disposal but does not cause hypoglycemia Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E280 - E286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bajaj, S. Suraamornkul, T. Pratipanawatr, L. J. Hardies, W. Pratipanawatr, L. Glass, E. Cersosimo, Y. Miyazaki, and R. A. DeFronzo Pioglitazone Reduces Hepatic Fat Content and Augments Splanchnic Glucose Uptake in Patients With Type 2 Diabetes Diabetes, June 1, 2003; 52(6): 1364 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Iozzo, K. Hallsten, V. Oikonen, K. A. Virtanen, J. Kemppainen, O. Solin, E. Ferrannini, J. Knuuti, and P. Nuutila Insulin-Mediated Hepatic Glucose Uptake Is Impaired in Type 2 Diabetes: Evidence for a Relationship with Glycemic Control J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2055 - 2060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Carey, J. Halliday, J. E. M. Snaar, P. G. Morris, and R. Taylor Direct assessment of muscle glycogen storage after mixed meals in normal and type 2 diabetic subjects Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E688 - E694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Basu, B. Di Camillo, G. Toffolo, A. Basu, P. Shah, A. Vella, R. Rizza, and C. Cobelli Use of a novel triple-tracer approach to assess postprandial glucose metabolism Am J Physiol Endocrinol Metab, January 1, 2003; 284(1): E55 - E69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Singhal, A. Caumo, P. E. Carey, C. Cobelli, and R. Taylor Regulation of endogenous glucose production after a mixed meal in type 2 diabetes Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E275 - E283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Shah, A. Vella, A. Basu, R. Basu, A. Adkins, W. F. Schwenk, C. M. Johnson, K. S. Nair, M. D. Jensen, and R. A. Rizza Effects of Free Fatty Acids and Glycerol on Splanchnic Glucose Metabolism and Insulin Extraction in Nondiabetic Humans Diabetes, February 1, 2002; 51(2): 301 - 310. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |